Back
Eton Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
56
ETON
Eton Pharmaceuticals
Last Price:
8.29
Seasonality Move:
10.53%
Buy
54
BMRN
Biomarin Pharmaceutical
Last Price:
66.00
Seasonality Move:
13.3%
Buy
56
Eton Pharmaceuticals (ETON)
is a Buy
Is Eton Pharmaceuticals a Buy, Sell or Hold?
- The current Eton Pharmaceuticals [ETON] share price is $8.35. The Score for ETON is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ETON is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.00. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ETON Stock Price Chart
What is Eton Pharmaceuticals's stock price today?
-
The Eton Pharmaceuticals share price today is $8.35
The current trend is moderately bullish and ETON is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.
ETON Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.6 | Buy |
Relative Strength Index (14 RSI): | 64.01 | Buy |
Chaikin Money Flow: | -44627 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.98 - 8.66) | Buy |
Bollinger Bands (100): | (3.19 - 6.83) | Buy |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.93 | Sell |
Relative Strength Index (14 RSI): | 29.43 | Sell |
Chaikin Money Flow: | -205272 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (67.87 - 70.73) | Sell |
Bollinger Bands (100): | (71.95 - 88.51) | Sell |
ETON Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.43 | Sell |
20-day SMA: | 8.19 | Buy |
50-day SMA: | 6.45 | Buy |
200-day SMA: | 4.46 | Buy |
8-day EMA: | 8.42 | Sell |
20-day EMA: | 7.98 | Buy |
50-day EMA: | 6.78 | Buy |
200-day EMA: | 4.9 | Buy |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 68.17 | Sell |
20-day SMA: | 69.24 | Sell |
50-day SMA: | 75.04 | Sell |
200-day SMA: | 82.85 | Sell |
8-day EMA: | 67.65 | Sell |
20-day EMA: | 69.3 | Sell |
50-day EMA: | 73.55 | Sell |
200-day EMA: | 81.57 | Sell |
Eton Pharmaceuticals Earnings Growth & ETON Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.71 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Eton Pharmaceuticals Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |